Prognostic impact of IKZF1 deletion in adults with common B-cell acute lymphoblastic leukemia

被引:0
|
作者
Qiu-Mei Yao
Kai-Yan Liu
Robert Peter Gale
Bin Jiang
Yan-Rong Liu
Qian Jiang
Hao Jiang
Xiao-Hui Zhang
Mei-Jie Zhang
Shan-Shan Chen
Xiao-Jun Huang
Lan-Ping Xu
Guo-Rui Ruan
机构
[1] Peking University People’s Hospital and Institute of Hematology,Beijing Key Laboratory of Hematopoietic Stem Cell Transplantation
[2] Imperial College London,Haematology Research Center, Division of Experimental Medicine, Department of Medicine
[3] Medical College of Wisconsin,Division of Biostatistics
[4] Peking-Tsinghua Center for Life Sciences,undefined
来源
BMC Cancer | / 16卷
关键词
Acute lymphoblastic leukemia; Chemotherapy; Allotransplant;
D O I
暂无
中图分类号
学科分类号
摘要
引用
下载
收藏
相关论文
共 50 条
  • [11] The many faces of IKZF1 in B-cell precursor acute lymphoblastic leukemia
    Marke, Rene
    van Leeuwen, Frank N.
    Scheijen, Blanca
    HAEMATOLOGICA, 2018, 103 (04) : 565 - 574
  • [12] IKZF1 Alterations and Therapeutic Targeting in B-Cell Acute Lymphoblastic Leukemia
    Paolino, Jonathan
    Tsai, Harrison K.
    Harris, Marian H.
    Pikman, Yana
    BIOMEDICINES, 2024, 12 (01)
  • [13] Prognostic significance of IKZF1 deletion in adult B cell acute lymphoblastic leukemia: a meta-analysis
    Zhang, Wanhua
    Kuang, Pu
    Li, He
    Wang, Fengjuan
    Wang, Yu
    ANNALS OF HEMATOLOGY, 2017, 96 (02) : 215 - 225
  • [14] Cuplike Nuclear Morphology in Pediatric B-cell Acute Lymphoblastic Leukemia is Highly Associated with IKZF1 Deletion
    Li, Weijie
    Cooley, Linda
    August, Keith
    Richardson, Aida
    MODERN PATHOLOGY, 2019, 32
  • [15] IKZF1 deletion is associated with a poor outcome in pediatric B-cell precursor acute lymphoblastic leukemia in Japan
    Asai, Daisuke
    Imamura, Toshihiko
    Suenobu, So-ichi
    Saito, Akiko
    Hasegawa, Daiichiro
    Deguchi, Takao
    Hashii, Yoshiko
    Matsumoto, Kimikazu
    Kawasaki, Hirohide
    Hori, Hiroki
    Iguchi, Akihiro
    Kosaka, Yoshiyuki
    Kato, Koji
    Horibe, Keizo
    Yumura-Yagi, Keiko
    Hara, Junichi
    Oda, Megumi
    CANCER MEDICINE, 2013, 2 (03): : 412 - 419
  • [16] Cuplike Nuclear Morphology in Pediatric B-cell Acute Lymphoblastic Leukemia is Highly Associated with IKZF1 Deletion
    Li, Weijie
    Cooley, Linda
    August, Keith
    Richardson, Aida
    LABORATORY INVESTIGATION, 2019, 99
  • [17] THE POOR PROGNOSTIC VALUE OF IKZF1-DELETION IN CHINESE ADULT COMMON B-CELL ACUTE LYMPHOBLASTIC LEUKEMIA AND THE SUPERIORITY OF STEM CELL TRANSPLANTATION OVER CHEMOTHERAPY FOR IKZF1 DELETED PATIENTS
    Yao, Q. M.
    Liu, K. Y.
    Xu, L. P.
    Liu, D. H.
    Zhang, X. H.
    Chen, Y. H.
    Jiang, Q.
    Jiang, H.
    Leng, X.
    Li, N.
    Li, L. D.
    Chang, Y.
    Li, J. L.
    Qin, Y. Z.
    Liu, Y. R.
    Jiang, B.
    Chen, S. S.
    Huang, X. J.
    Ruan, G. R.
    HAEMATOLOGICA, 2014, 99 : 8 - 9
  • [18] Frequency of IKZF1 Deletions in a Peruvian Population with B-Cell Acute Lymphoblastic Leukemia
    Enriquez, Daniel J.
    Mitchell, Rachel J.
    Alapi, Krisztina Zuborne
    Cervantes, Elizabeth
    Cancino, Karina
    Casas, Jhoysi
    Valcarcel, Bryan
    Sandival, Gustavo
    Haro, Juan C.
    Samanez-Figari, Cesar
    Zapata, Arturo
    Garcia-Leon, Juan L.
    Fielding, Adele K.
    BLOOD, 2020, 136
  • [19] IKZF1 Deletions are Independent Prognostic Factor in Pediatric B-Cell Precursor Acute Lymphoblastic Leukemia in Russia
    Tsaur, G.
    Druy, A.
    Solodonikov, A.
    Popov, A.
    Shapochnik, A.
    Vlasova, A.
    Vakhonina, L.
    Riger, T.
    Verzhbitskaya, T.
    Olshanskaya, Yu.
    Shorikov, E., V
    Arakaev, O. R.
    Saveliev, L., I
    Fechina, L. G.
    ANNALS OF HEMATOLOGY, 2017, 96 : S79 - S80
  • [20] IKZF1 Deletions as a Prognostic Factor in Costa Rican Patients With Pediatric B-Cell Acute Lymphoblastic Leukemia
    Granados-Zamora, Melissa
    Chaves-Herrera, Karla
    Morera-Araya, Estela
    Granados-Alfaro, Paola
    Valverde-Munoz, Kathia
    Soto-Herrera, Gabriela
    Santamaria-Quesada, Carlos
    JOURNAL OF PEDIATRIC HEMATOLOGY ONCOLOGY, 2020, 42 (06) : E401 - E406